Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome;
Filgueira, CS, Nicolov, E, Hood, RL, Ballerini, A, Garcia-Huidobro, J, Lin, JZ, Fraga, D, Webb, P, Sabek, O, Gaber, AO, Phillips, KJ & Grattoni, A 2016, International Journal of Obesity. DOI:

Structural dataset for the PPAR? V290M mutant;
Puhl, AC, Webb, P & Polikarpov, I 2016, Data in Brief, vol 7, pp. 1430-1437. DOI:

Obesity, Inflammation, and Cancer;
Deng, T, Lyon, CJ, Bergin, S, Caligiuri, MA & Hsueh, WA 2016, Annual Review of Pathology: Mechanisms of Disease, vol 11, pp. 421-449. DOI:

Calix[3]carbazole: One-Step Synthesis and Host-Guest Binding;
Yang, P, Jian, Y, Zhou, X, Li, G, Deng, T, Shen, H, Yang, Z & Tian, Z 2016, Journal of Organic Chemistry, vol 81, no. 7, pp. 2974-2980. DOI:

Gustafsson, JA & Webb, P 2016, Journal of Steroid Biochemistry and Molecular Biology, vol 157, pp. 1-2. DOI:

TLX: An elusive receptor;
Benod, C, Villagomez, R & Webb, P 2016, Journal of Steroid Biochemistry and Molecular Biology, vol 157, pp. 41-47. DOI:

Sobetirome: The past, present and questions about the future;
Lammel Lindemann, J & Webb, P 2016, Expert Opinion on Therapeutic Targets, vol 20, no. 2, pp. 145-149. DOI:

Pharmacophore elucidation of phosphoiodyn A - Potent and selective peroxisome proliferator-activated receptor ß/d agonists with neuroprotective activity;
Kinarivala, N, Suh, JH, Botros, M, Webb, P & Trippier, PC 2016, Bioorganic and Medicinal Chemistry Letters. DOI:

Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional Conversion of White to Brown Fat;
Lin, JZ, Martagón, AJ, Cimini, SL, Gonzalez, DD, Tinkey, DW, Biter, A, Baxter, JD, Webb, P, Gustafsson, JÅ, Hartig, SM & Phillips, KJ 2015, Cell Reports, vol 13, no. 8, pp. 1528-1537. DOI:

Similarities and distinctions in actions of surface-directed and classic androgen receptor antagonists;
Suh, JH, Chattopadhyay, A, Sieglaff, DH, Samaniego, CS, Cox, MB & Webb, P 2015, PLoS ONE, vol 10, no. 9, e0137103. DOI: